Axis Mutual Fund decreased its stake in Onesource Specialty Pharma Limited from 1.47% to 1.33% by selling 155,669 shares. The value of the shares sold is ₹24.43 crore at ₹1571.30 apiece.
A specialist pharmaceutical company engaged in the research, development, and manufacturing of biological drug products in injectable formats for therapeutic use. OneSource Specialty Pharma provides comprehensive contract development and manufacturing organization services spanning all phases of preclinical and clinical development, alongside commercial supply of biologics to domestic and international pharmaceutical clients and healthcare providers.
Subsidiary of Axis Bank, India's third-largest private sector bank. Manages over Rs 3.5 lakh crore in AUM. Built its brand on a quality growth equity philosophy with concentrated high-conviction portfolios. Flagship Axis Flexi Cap and Axis Bluechip funds are widely held among retail investors and drove significant AUM growth through the 2017-2021 bull cycle.